Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer

HIGHLIGHTS

• who: Masanori Oshi from the (UNIVERSITY) have published the article: Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer, in the Journal: (JOURNAL)
• what: This finding led the authors to this study where the authors investigated the clinical relevance of immune activity in breast cancer. The authors demonstrated that the immune_response, quantified by the allograft rejection score, is associated with better survival in TNBC, but not in ER-positive/ HER2-negative breast cancer.
• how: Biomedical research is evolving rapidly to revolutionize the way molecular . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.